NYSE:FMS

Fresenius Medical Care AG & Co. KGaA Price Target, Predictions & Analyst Ratings

$38.16
+0.56 (+1.49 %)
(As of 04/12/2021 05:06 PM ET)
Add
Compare
Today's Range
$37.76
Now: $38.16
$38.20
50-Day Range
$34.37
MA: $36.13
$37.58
52-Week Range
$33.84
Now: $38.16
$46.55
Volume330,785 shs
Average Volume473,828 shs
Market Capitalization$22.35 billion
P/E Ratio15.14
Dividend Yield1.33%
Beta1.21

Analyst Ratings

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
17 Wall Street analysts have issued ratings and price targets for Fresenius Medical Care AG & Co. KGaA in the last 12 months. Their average twelve-month price target is $45.00, predicting that the stock has a possible upside of 17.92%. The high price target for FMS is $48.00 and the low price target for FMS is $42.00. There are currently 1 sell rating, 9 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
FMS Consensus Rating: HoldHoldBuyBuy
FMS Consensus Rating Score: 2.352.352.792.79
FMS Analyst Ratings: 1 Sell Rating(s)
9 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
FMS Consensus Price Target: $45.00$45.00$45.13$45.13
FMS Price Target Upside: 17.92% upside13.96% upside13.76% upside13.76% upside

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/2/2021Berenberg BankReiterated RatingBuyMedium
2/26/2021JPMorgan Chase & Co.Reiterated RatingNeutralLow
2/24/2021TruistDowngradeBuy ➝ HoldLow
2/17/2021UBS GroupReiterated RatingBuyMedium
2/4/2021BNP ParibasDowngradeOutperform ➝ NeutralLow
2/4/2021Exane BNP ParibasDowngradeOutperform ➝ NeutralMedium
2/4/2021Kepler Capital MarketsDowngradeBuy ➝ HoldLow
2/3/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldLow
2/3/2021DZ BankReiterated RatingBuyLow
2/3/2021The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
2/2/2021BarclaysReiterated RatingOverweightLow
2/1/2021Stifel NicolausDowngradeBuy ➝ HoldLow
1/11/2021Jefferies Financial GroupDowngradeHold ➝ UnderperformMedium
1/6/2021Nord/LBReiterated RatingBuyN/A
12/9/2020Morgan StanleyReiterated RatingEqual WeightLow
11/19/2020Royal Bank of CanadaReiterated RatingNeutralLow
5/21/2020SunTrust BanksBoost Price TargetBuy$46.00 ➝ $48.00Low
2/21/2020CfraUpgradeHold ➝ Buy$38.00 ➝ $46.00Low
10/23/2019Redburn PartnersReiterated RatingBuy ➝ NeutralLow
8/1/2019BTIG ResearchDowngradeBuy ➝ NeutralLow
5/9/2019CommerzbankReiterated RatingHold$54.00Low
8/28/2018HSBCUpgradeHold ➝ BuyLow
7/9/2018Bank of AmericaInitiated CoverageBuyLow
7/5/2018Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
(Data available from 4/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.